logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Class
    3. Anti-anginal

    Anti-anginal class drugs

    FiltersReset Filters
    4 results

    • ranolazine

      (Ranolazine)
      Zydus Lifesciences Limited
      Usage: Ranolazine extended-release tablets are indicated for the treatment of chronic angina and can be used alongside various medications, including beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering agents, ACE inhibitors, and angiotensin receptor blockers.

    • ranolazine

      (RANOLAZINE)
      AvKARE
      Usage: Ranolazine extended-release tablets are indicated for the treatment of chronic angina and may be used in combination with various cardiovascular medications, including beta-blockers, nitrates, and ACE inhibitors.

    • ranolazine

      (Ranolazine)
      Ajanta Pharma USA Inc.
      Usage: Ranolazine extended-release tablets are indicated for the treatment of chronic angina and can be used in conjunction with various medications, including beta-blockers, nitrates, and other cardiovascular therapies.

    • ranolazine

      (Ranolazine)
      Viona Pharmaceuticals Inc
      Usage: Ranolazine extended-release tablets are indicated for the treatment of chronic angina and can be used alongside various other therapies, including beta-blockers, nitrates, and lipid-lowering agents.